Abacavir sulphate 300 mg

Products

Information

Cipla Ltd offers wide range of formulation products which includes abacavir sulphate 300 mg. Dosage form: tablets. Therapeutic area: hiv-aids. Packaging type: container. Contact us for more information.
Main Categories
Finished Dosage Forms
All Categories
Finished Dosage Forms
Distribution areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from
India
Cipla LtdCipla laid foundations for the Indian pharmaceutical industry back in 1935 with the vision to make India self-reliant in healthcare. Over the years Cipla has emerged as one of the most respected names not just in India but worldwide. Its state of the art R&D centre and manufacturing units has given the country and the world many firsts. Cipla has earned a name for maintaining one global standard for its products and services in over 180 countries. Cipla continues to support, improve and save millions of lives with its high-quality drugs and innovative devices.

Log in

See all the content and easy-to-use features by logging in or registering!